By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts ...

Shares of major vaccine makers Moderna and Pfizer held steady even as U.S. health secretary Robert F. Kennedy Jr. abruptly ...

Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...

A new Canadian real-world study, ACTIONS (chAracterizing oral Corticosteroid use in patients with chronic rhInOsinusitis with ...

After combining on the development of five malaria vaccine candidates since 2016, Swedish CDMO Recipharm and the University ...

With precious little to report out of Sino-U.S. trade talks in London, investors are ready to pounce on almost any sign a ...

AnaptysBio offers significant upside, with fair value estimates nearly double its current market cap if RA approval is ...

BioSpace did a deep dive into executive pay, examining the highest compensation packages, pay ratios and golden ...

Following a landmark gathering of over 2,200 life sciences supply chain leaders in April, LogiPharma’s 25th anniversary ...

UK firm will donate 10% of client fees to fund that will split proceeds with the Access to Justice Foundation and Just4Kids ...

DataM Intelligence | competitive Intelligence Lupus nephritis affects up to 60% of SLE patients, with limited FDA-approved options like Ben ...